Previous post
Roche’s Elecsys® pTau181 Becomes the Only FDA-Cleared Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology
Next post
The Global CEO Initiative on Alzheimer’s Disease Publishes Consensus Recommendations for Clinic-Based Digital Cognitive Assessments